Skip to main content

Table 3 Interobserver Agreement for LI-RADS Categorization and Imaging Features of HCCs on Gadoxetic acid and gadopentetate dimeglumine

From: Comparison of gadoxetic acid versus gadopentetate dimeglumine for the detection of hepatocellular carcinoma at 1.5 T using the liver imaging reporting and data system (LI-RADS v.2017)

Interobserver agreement

Gadoxetic acid

gadopentetate dimeglumine

LR-5 assigment

0.813(0.721–0.903)

0.798(0.712–0.884)

LR-4 assigment

0.746(0.646–0.846)

0.696(0.598–0.794)

LR-1 assigment

0.698(0.596–0.800)

0.712(0.612–0.812)

Casual appearance

0.734(0.612–0.856)

0.689(0.562–0.816)

Aterial hyperenhancement

0.773(0.642–0.904)

0.712(0.598–0.826)

  1. Data are kappa values. Data in parentheses are 95% confidence intervals
Back to article page

Cancer Imaging

ISSN: 1470-7330

Contact us